EUVIMEDEUVIMED entdecken
BeobachtungsstudieValidierungsstudieOpen Access

Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates

Kevin C Zhang, Nikhil Narang, Carine Jasseron, Richard Dorent, Kevin A Lazenby, Mark N Belkin, Jonathan Grinstein, Anoop Mayampurath, Matthew M Churpek, Kiran K Khush, William F Parker

JAMA · 13.02.2024 · 331 (6) · 500

DOI: 10.1001/jama.2023.27029 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JAMA, erschienen am 13.02.2024. Verfasst von Kevin C Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Chicago, Chicago, Illinois. Hauptthemen laut MEDLINE: Heart Transplantation, Heart Failure, Tissue and Organ Procurement. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The US heart allocation system prioritizes medically urgent candidates with a high risk of dying without transplant. The current therapy-based 6-status system is susceptible to manipulation and has limited rank ordering ability.

Objective

To develop and validate a candidate risk score that incorporates current clinical, laboratory, and hemodynamic data. Design, Setting, and Participants A registry-based observational study of adult heart transplant candidates (aged ≥18 years) from the US heart allocation system listed between January 1, 2019, and December 31, 2022, split by center into training (70%) and test (30%) datasets. Adult candidates were listed between January 1, 2019, and December 31, 2022. Main Outcomes and Measures A US candidate risk score (US-CRS) model was developed by adding a predefined set of predictors to the current French Candidate Risk Score (French-CRS) model. Sensitivity analyses were performed, which included intra-aortic balloon pumps (IABP) and percutaneous ventricular assist devices (VAD) in the definition of short-term mechanical circulatory support (MCS) for the US-CRS. Performance of the US-CRS model, French-CRS model, and 6-status model in the test dataset was evaluated by time-dependent area under the receiver operating characteristic curve (AUC) for death without transplant within 6 weeks and overall survival concordance (c-index) with integrated AUC.

Results

A total of 16 905 adult heart transplant candidates were listed (mean [SD] age, 53 [13] years; 73% male; 58% White); 796 patients (4.7%) died without a transplant. The final US-CRS contained time-varying short-term MCS (ventricular assist–extracorporeal membrane oxygenation or temporary surgical VAD), the log of bilirubin, estimated glomerular filtration rate, the log of B-type natriuretic peptide, albumin, sodium, and durable left ventricular assist device. In the test dataset, the AUC for death within 6 weeks of listing for the US-CRS model was 0.79 (95% CI, 0.75-0.83), for the French-CRS model was 0.72 (95% CI, 0.67-0.76), and 6-status model was 0.68 (95% CI, 0.62-0.73). Overall c-index for the US-CRS model was 0.76 (95% CI, 0.73-0.80), for the French-CRS model was 0.69 (95% CI, 0.65-0.73), and 6-status model was 0.67 (95% CI, 0.63-0.71). Classifying IABP and percutaneous VAD as short-term MCS reduced the effect size by 65%. Conclusions and Relevance In this registry-based study of US heart transplant candidates, a continuous multivariable allocation score outperformed the 6-status system in rank ordering heart transplant candidates by medical urgency and may be useful for the medical urgency component of heart allocation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationHeart FailureTissue and Organ ProcurementAdultFemaleHumansMaleMiddle AgedBilirubinClinical Laboratory ServicesHeartRisk FactorsRisk AssessmentUnited StatesHealth Care RationingPredictive Value of Tests

Substanzen

Bilirubin

Autor:innen und Institutionen

  • Department of Medicine, University of Chicago, Chicago, Illinois.
  • Advocate Heart Institute, Advocate Christ Medical Center, Oak Lawn, Illinois.
  • Department of Medicine, University of Illinois-Chicago.
  • Agence de la Biomédecine, Direction Prélèvement Greffe Organes-Tissus, Saint-Denis La Plaine, France.
  • Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
  • Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Zhang, K. C., Narang, N., Jasseron, C., Dorent, R., Lazenby, K. A., Belkin, M. N., Grinstein, J., Mayampurath, A., Churpek, M. M., Khush, K. K., & Parker, W. F. (2024). Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates. JAMA, 331(6), 500. https://doi.org/10.1001/jama.2023.27029

Vancouver

Zhang KC, Narang N, Jasseron C, Dorent R, Lazenby KA, Belkin MN, et al. Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates. JAMA. 2024;331(6):500. doi:10.1001/jama.2023.27029

BibTeX
@article{Zhang2024,
  author = {Zhang, Kevin C and Narang, Nikhil and Jasseron, Carine and Dorent, Richard and Lazenby, Kevin A and Belkin, Mark N and Grinstein, Jonathan and Mayampurath, Anoop and Churpek, Matthew M and Khush, Kiran K and Parker, William F},
  title = {Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates},
  journal = {JAMA},
  year = {2024},
  volume = {331},
  number = {6},
  pages = {500},
  doi = {10.1001/jama.2023.27029}
}
Kostenlos starten →